Authors : Dr. Md. Akmal Ariff; Dr. Arunachalam Sudheer; Dr. Soumalya Banerjee; Dr. Susmita Mondal; Dr. Priya; Dr. Abhilash

Volume/Issue : Volume 10 - 2025, Issue 6 - June

Google Scholar : https://tinyurl.com/2vbs7psd

DOI : https://doi.org/10.38124/ijisrt/25jun1656

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Introduction: Dental implant survival is influenced to a certain extent by systemic situation and habits. Surgical success is worsened by conditions that impair the natural healing cascade. However, a disease's revealing existence does not always preclude out implant therapy or have an enormous effect on long-term results. With appropriate management, certain conditions or additional factors can allow implant survival rates to approach those seen in healthy individuals. Patients who do not have systemic or local contraindications to therapy should be chosen in order to ensure implant success.  Objective: It has been proposed that certain illnesses and medically compromised stipulations may contraindicate dental implant treatment. This article targets figuring out the precautions to take and analysing whether dental implants' effectiveness and long-term survival rates are poorer in patients with deteriorated health.  Source: Using the PubMed/Medline, Scopus, Scirus, and Cochrane databases, an extensive literature review was conducted through digging up keywords and medically confronted diseases that influence implants.  Conclusion: Although a variety of disorders may raise the probability of treatment failure or complications, there are very few specific health risks to dental implant therapy. Since the quality of life and functional benefits associated with dental implants may outweigh any risks for many of these patients, the degree of systemic disease control may be significantly greater than the nature of the disorder itself. Individualized medical control should be established before implant therapy.

References :

1. Belir A, Bora N, Yusuf E, Ozgür B, Buket A, Serhat YI. Immediate implant placement without bone grafting: a retrospective study of 110 cases with 5 years of follow-up. Implant Dent. 2013;22:360–5.
2. Meijndert CM, Raghoebar GM, Meijndert L, Stellingsma K, Vissink A, Meijer HJ. Single implants in the aesthetic region preceded by local ridge augmentation; a 10-year randomized controlled trial. Clin Oral Implants Res. 2017;28:388–95.
3. Diz P, Scully C, Sanz M. Dental implants in the medically compromised patient. J Dent. 2013;41:195–206.
4. Sugerman PB, Barber MT. Patient selection for endosseous dental implants: oral and systemic considerations. International Journal of Oral and Maxillofacial Implants 2002;17:191–201.
5. Balshi TJ, Wolfinger GJ. Management of the posterior maxilla in the compromised patient: historical, current, and future perspectives. Periodontology 2000 2003;33:67–81.
6. Hwang D, Wang HL. Medical contraindications to implant therapy. Part II. Relative contraindications. Implant Dentistry 2007;16:13–23.
7. Hwang D, Wang HL. Medical contraindications to implant therapy. Part I. Absolute contraindications. Implant Dentistry 2006;15:353–60.
8. Marcello-Machado RM, Faot F, Schuster AJ, Bielemann AM, Chagas Júnior OL, Del Bel Cury AA. How does mandibular bone atrophy influence the masticatory function, OHRQoL and satisfaction in overdenture wearers? Clinical results until 1 year post- loading. J Oral Rehabil. 2017;13:43–7.
9. Brignardellopetersen R. Tooth loss, periodontal disease, and dental caries may be associated with decreased oral health-related quality of life, but there is no evidence About the magnitude of this association. J Am Dent Assoc. 2017;148:e150.
10. Morita M, Kimura T, Kanegae M, Ishikawa A, Watanabe T. Reasons for extraction of permanent teeth in Japan. Community Dent Oral Epidemiol. 1994;22:303–6.
11. Pjetursson BE, Thoma D, Jung R, Zwahlen M, Zembic A. A systematic review of the sur- vival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clin Oral Implants Res. 2012;23:22–8.
12. Emami E, de Souza RF, Kabawat M, Feine JS. The impact of edentulism on oral and general health. Int J Dent. 2013;2013:498305.
13. Eaton KA. The platform for better oral health in Europe—report of a new initiative. Community Dent Health. 2012;29:131.
14. Jablonowski L, Matthes R, Duske K, Kocher T. Perspectives in dental implantology. In: Metelmann HR, von Woedtke T, Weltmann KD, editors. Comprehensive clinical plasma medi- cine. Cham: Springer; 2018. p. 319–30.
15. Cairo F, Landi L, Gatti C, Rasperini G, Aimetti M. Tooth loss and dental implant outcomes— where is dentistry going? A survey by SIdP, the Italian Society of Periodontology and Implantology. Oral Dis. 2018;24:1379–81.
16. Busenlechner D, Fürhauser R, Haas R, Watzek G, Mailath G, Pommer B. Long-term implant success at the academy for oral implantology: 8-year follow-up and risk factor analysis. J Periodontal Implant Sci. 2014;44:102–8.
17. Ellen Cristina GJ, Joel Ferreira SJ, Marcelo Coelho G, Eduardo Piza P, Osvaldo MF, Elerson Gaetti JJ. Dental implants in patients with osteoporosis: a clinical reality? J Craniofac Surg. 2011;22:1111–3.
18. Taschieri S, Lolato A, Testori T, Francetti L, Del Fabbro M. Short dental implants as compared to maxillary sinus augmentation procedure for the rehabilitation of edentulous poste- rior maxilla: three-year results of a randomized clinical study. Clin Implant Dent Relat Res. 2017;20(Suppl 1):9–20.
19. Lopez Torres JA, Gehrke SA, Calvo Guirado JL, Aristazábal LFR. Evaluation of four designs of short implants placed in atrophic areas with reduced bone height: a three-year, retrospective, clinical and radiographic study. Br J Oral Maxillofac Surg. 2017;55:703.
20. Marco E, Roberto P, Carlo B, Pietro F. Three-year results from a randomised controlled trial comparing prostheses supported by 5-mm long implants or by longer implants in augmented bone in posterior atrophic edentulous jaws. Eur J Oral Implantol. 2014;7:383– 95.
21. Lindh T, Gunne J, Tillberg A, Molin M. A meta-analysis of implants in partial edentulism. Clincal Oral Implants Res 1998;9(2):80–90.
22. Schoen F. The heart. In: Kumar V, ed. Robbins and Cotran: Pathologic Basis of Disease. 7th ed. St. Louis, MO: Saunders; 2005:584-586.
23. Zivan J. Approach to cerebrovascular diseases. In: Goldman L, ed. Cecil Text- book of Medicine. 22nd ed. St. Louis, MO: Saunders; 2004:2280-2287
24. Khadivi V, Anderson J, Zarb GA. Cardiovascular disease and treatment outcomes with osseointegration surgery. Journal of Prosthetic Dentistry 1999;81:533–6.
25. Alsaadi G, Quirynen M, Koma ́rek A, van Steenberghe D. Impact of local and systemic factors on the incidence of late oral implant loss. Clinical Oral Implants Research 2008;19: 670–6.
26. Alsaadi G, Quirynen M, Koma ́rek A, van Steenberghe D. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. Journal of Clinical Periodontology 2007;34:610–7.
27. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. International Journal of Oral and Maxillofacial Implants 2005;20:569–77.
28. Romano MM, Soares MS, Pastore CA, Tornelli MJ, de Oliveira Guare ́ R, Adde CA. A study of effectiveness of midazolam sedation for prevention of myocardial arrhythmias in endosseous implant placement. Clinical Oral Implants Research 2012;23:489–95.
29. Chambers H. Infective endocarditis. In: Goldman L, ed. Cecil Textbook of Medicine. 22nd ed. St. Louis, MO: Saunders; 2004:1795-1796.
30. Baab DA, Ammons WF Jr, Selipsky H. Blood loss during periodontal flap surgery. J Periodontology. 1977;48:693-698.
31. Fazio RC, Fang LST. Bleeding disorders. In: Sonis ST, Fazio RC, Fang LST, eds. Oral Medicine Secrets. 1st ed. Philadelphia, PA: Hanley & Belfus, Inc.; 2003:113.
32. Fazio RC, Fang LST. Bleeding disorders. In: Sonis ST, Fazio RC, Fang LST, eds. Oral Medicine Secrets. 1st ed. Philadelphia, PA: Hanley & Belfus, Inc.; 2003:113.
33. Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-based guide- lines. Chest. 2004;126:172S-696S.
34. Drews RE. Critical issues in haematology: Anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med. 2003;24:607-622.
35. Jolly DE. Interpreting the clinical laboratory. J Calif Dent Assoc. 1995;23: 32-40.
36. Brogniez V, Nyssen-Behets C, Gregoire V, et al. Implant osseointegration in the irradiated mandible. A comparative study in dogs with a microradiographic and histologic assessment. Clin Oral Im- plants Res. 2002;13:234-242.
37. Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64:379-390.
38. KarrRA, KramerDC, TothBB. Dental implants and chemotherapy complications. J Prosthet Dent. 1992;67:683-687.
39. Steiner M, Windchy A, Gould AR, et al. Effects of chemotherapy in patients with dental implants. J Oral Implantol. 1995;21:142-147.
40. Fugazzotto PA. Success and failure rates of osseointegrated implants in function in regenerated bone for 6 to 51 months: A preliminary report. Int J Oral Maxillofac Implants. 1997;12:17-24.
41. De Lange G, Tadjoedin E. Fate of the HA coating of loaded implants in the augmented sinus floor: A human case study of retrieved implants. Int J Periodontics Restorative Dent. 2002;22: 287-296.
42. Piattelli A, Scarano A, Vaia E, et al. Histological evaluation of the peri-implant bone around plasma-sprayed non- submerged titanium implants retrieved from man: A report of two cases. Biomaterials. 1996;17:2219-2224.
43. Kennedy J. Alcohol use disorders. In: Jacobson J, ed. Psychiatric Secrets. 2nd ed. Philadelphia, PA: Hanley & Belfus; 2001:103.
44. American Academy of Periodontology Statement on Bisphosphonates. August 26, 2005. Available at: http://www.perio. org/resources-products/bisphosphonates. htm. Accessed August 27, 2006.
45. American Dental Association. Osteonecrosis of the jaw. July 12, 2006. Available at: http://www.ada.org/prof/ resources/topics/osteonecrosis.asp. Ac- cessed August 27, 2006.
46. Schliephake H, Sicilia A, Nawas BA, Donos N, Gruber R, Jepsen S, et al. Drugs and diseases: Summary and consensus statements of group 1. The 5(th) EAO Consensus Conference 2018. Clin Oral Implants Res. 2018;29(Suppl 18):93–9.
47. Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Schiodt M, Klinge B. The effect of antire- sorptive drugs on implant therapy: systematic review and meta-analysis. Clin Oral Implants Res. 2018;29(Suppl 18):54–92.
48. Goodburn EA, Ross DA. A picture of health: A review and annotated bibliography of the health of young people in developing countries. New York: World Health Organization and Unicef, 1995.
49. Sennerby L, Odman J, Lekholm U, et al. Tissue reactions towards titanium im- plants inserted in growing jaws. A histolog- ical study in the pig. Clin Oral Implants Res. 1993;4:65-75.
50. Cronin RJ Jr, Oesterle LJ, Ranly DM. Mandibular implants and the growing patient. Int J Oral Maxillofac Implants. 1994;9:55-62.
51. Kearns G, Sharma A, Perrott D, et al. Placement of endosseous implants in children and adolescents with hereditary ectodermal dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88: 5-10.
52. Mericske-Stern R, Zarb GA. Overdentures: An alternative implant methodology for edentulous patients. Int J Prosthodont. 1993;6:203-8.
53. ZarbGA,SchmittA.Osseointegra- tion for elderly patients: The Toronto study. J Prosthet Dent. 1994;72:559-568.
54. Roynesdal AK, Amundrud B, Hannaes HR. A comparative clinical inves- tigation of 2 early loaded ITI dental implants supporting an overdenture in the mandi- ble. Int J Oral Maxillofac Implants. 2001; 16:246-251.
55. Bryant SR, Zarb GA. Osseointe- gration of oral implants in older and younger adults. Int J Oral Maxillofac Im- plants. 1998;13:492-499.
56. Kondell PA, Nordenram A, Landt H. Titanium implants in the treatment of edentulousness: Influence of patient’s age on prognosis. Gerodontics. 1988;4:280- 284.
57. Gadeleta SJ, Boskey AL, Paschalis E, et al. A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate- treated cynomolgus monkeys (Macaca fas- cicularis). Bone. 2000;27:541-550.
58. Parfitt AM. Bone remodeling. Henry Ford Hosp Med J. 1988;36:143- 144.
59. August M, Chung K, Chang Y, et al. Influence of estrogen status on endosseous implant osseointegration. J Oral Max- illofac Surg. 2001;59:1285-1289.
60. Friberg B , Ekestubbe A, Mellstrom D, et al. Brånemark implants and osteoporosis: A clinical exploratory study. Clin Implant Dent Relat Res. 2001;3: 50-56.
61. Langdahl BL, Ljunggren O, Benhamou CL, Marin F, Kapetanos G, Kocjan T, et al. Fracture rate, quality of life and Back pain in patients with Osteoporosis treated with Teriparatide: 24-month results from the extended Forsteo observational study (ExFOS). Calcif Tissue Int. 2016;99:259–12.
62. De Medeiros F, Kudo GAH, Leme BG, Saraiva PP, Verri FR, Honorio HM, et al. Dental implants in patients with osteoporosis: a systematic review with meta-analysis. Int J Oral Maxillofac Surg. 2018;47:480–11.
63. Merheb J, Temmerman A, Rasmusson L, Kubler A, Thor A, Quirynen M. Influence of skeletal and local bone density on dental implant stability in patients with Osteoporosis. Clin Implant Dent Relat Res. 2016;18:253–7.
64. Dvorak G, Arnhart C, Heuberer S, Huber CD, Watzek G, Gruber R. Peri-implantitis and late implant failures in postmenopausal women: a cross-sectional study. J Clin Periodontol. 2011;38:950–5.
65. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants. 2005;20:569–8.
66. Hansen T, Kunkel M, Weber A, James Kirkpatrick C. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison withinfected osteoradionecrosis. J Oral Pathol Med. 2006;35:155.
67. Guarneri V, Miles D, Robert N, Dieras V, Glaspy J, Smith I, et al. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat. 2010;122:181–8.
68. Lambert PM, Morris HF, Ochi S. The influence of smoking on 3-year clinical success of osseointegrated dental im- plants. Ann Periodontol. 2000;5:79-89.
69. House NOHPC. Oral health messages for the Australian public. Findings of a national consensus workshop. Aust Dent J. 2011;56:331–5.
70. Moraschini V, Barboza EDP. Success of dental implants in smokers and non- smokers: a sys- tematic review and meta-analysis. Int J Oral Maxillofac Surg. 2016;45:205–15.
71. Ramberg P, Rosling B, Serino G, Hellstrom MK, Socransky SS, Lindhe J. The long- term effect of systemic tetracycline used as an adjunct to non-surgical treatment of advanced periodontitis. J Clin Periodontol. 2001;28:446–52.
72. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64–71.
73. Group TDCaCTDR. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol. 1995;75:894–903
74. Beikler T, Flemmig TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med. 2003;14:305–16.
75. Nevins ML, Karimbux NY, Weber HP, Giannobile WV, Fiorellini JP. Wound healing around endosseous implants in experimental diabetes. Int J Oral Maxillofac Implants. 1998;13:620–9.
76. Hamann C, Kirschner S, Günther K-P, Hofbauer LC. Bone, sweet bone—osteoporotic frac- tures in diabetes mellitus. Nat Rev Endocrinol. 2012;8:297–305.
77. Khandelwal N, Oates TW, Vargas A, Alexander PP, Schoolfield JD, Alex MMC. Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus—a randomized controlled trial. Clin Oral Implants Res. 2013;24:13–9.
78. Morris HF, Ochi S, Winkler S. Implant survival in patients with type 2 diabetes: placement to 36 months. Ann Periodontol. 2000;5:157.
79. Von Wilmowsky C, Stockmann P, Harsch I, Amann K, Metzler P, Lutz R, et al. Diabetes mellitus negatively affects peri-implant bone formation in the diabetic domestic pig. J Clin Periodontol. 2011;38:771–9.
80. Ormianer Z, Block J, Kohen J. The effect of moderately controlled type 2 diabetes on den- tal implant survival and peri-implant bone loss: a long-term retrospective study. Int J Oral Maxillofac Implants. 2018;33:389–94.
81. Van Steenberghe D, Jacobs R, Desnyder M, et al. The relative impact of local and endogenous patient-related fac- tors on implant failure up to the abutment stage. Clin Oral Implants Res. 2002;13: 617-622.
82. Olin B, Hebel S, Dombek C, editors. Drug facts and comparisons. St Louis, Mo: Facts and Comparisons, Inc.; 2007.
83. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165:1095–106.
84. Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology. 2008;109:588–95.
85. Oliva X, Oliva J, Oliva JD. Full-mouth oral rehabilitation in a titanium allergy patient using zirconium oxide dental implants and zirconium oxide restorations. A case report from an ongoing clinical study. European Journal of Esthetic Dentistry 2010;5:190–203.
86. Baptista F, Varela A, Sardinha LB. Bonemineral mass in males and females withand without Down syndrome. Osteoporosis Int 2005;16:380–388.
87. Bradley JC. Age changes in the vascular supply of the mandible. Br Dent J. 1972;132:142-144.
88. MinakoYT:Vascular endothelial glycocalyxCOVID-19. Int J Mol Sci 21:9712, 2020
89. Lowenstein CJ, Solomon SD: Severe COVID-19 is a microvascular disease Circulation. Circulation 142:1609–1611, 2020
90. Craik DJ, Fairlie DP, Liras S, et al. The future of peptide-based drugs. Chem Biol Drug Des. 2013;81(1):136–47.
91. Tsuchiya S, Sugimoto K, Omori M, et al. Mandibular osteomyelitis implicated in  infliximab and periapical periodontitis: A case report. J Oral Maxillofac Surg Med Pathol. 2016; 28(5):410–5.
92. Cillo JE Jr, Barbosa N. Adalimumab-Related Dental Implant Infection. J Oral Maxillofac Surg. 2019;77(6):1165–9.
93. Radfar L, Ahmadabadi RE, Masood F, et al. Biological therapy and dentistry: a review paper. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(5):594-601.